CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
Open Access
- 6 July 2021
- journal article
- review article
- Published by Elsevier in Journal of Advanced Research
- Vol. 40, 207-221
Abstract
No abstract availableKeywords
Funding Information
- Murdoch Children's Research Institute
- Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
- United Arab Emirates University
- Takeda Science Foundation
This publication has 92 references indexed in Scilit:
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Genetics: Finding risk factorsNature, 2011
- Disease-modifying treatments for Alzheimer’s diseaseTherapeutic Advances in Neurological Disorders, 2011
- APP processing in Alzheimer's diseaseMolecular Brain, 2011
- Chinese Presenilin-1 V97L mutation enhanced Aβ42 levels in SH-SY5Y neuroblastoma cellsNeuroscience Letters, 2006
- Site-Specific Integration of Functional Transgenes into the Human Genome by Adeno/AAV Hybrid VectorsMolecular Therapy, 2004
- Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1Neuron, 2003
- Human Apolipoprotein E4 Domain InteractionJournal of Biological Chemistry, 1996
- Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14Science, 1992
- A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloidNature Genetics, 1992